BioNxt Solutions Inc. Announces Private Placement Initiative

BioNxt Solutions Inc., a bioscience company based in Vancouver, has announced a non-brokered private placement of units, aiming to raise up to $2 million. Each unit is priced at $0.33, and a total of 6,060,606 units will be available under the Listed Issuer Financing exemption. This initiative is designed to support the company's European R&D operations and general corporate purposes.

Each unit comprises one common share and one warrant. The warrant allows the holder to acquire an additional share at $0.50 within 24 months post-closing. The company will also pay a 6% finder’s fee in connection with the sale.

The offering is anticipated to close by July 27, 2026, pending necessary approvals. BioNxt prioritizes advancing drug delivery technologies, diagnostic screenings, and pharmaceutical ingredient developments, mainly targeting European markets.